MY198747A - Composition for external use - Google Patents

Composition for external use

Info

Publication number
MY198747A
MY198747A MYPI2019003643A MYPI2019003643A MY198747A MY 198747 A MY198747 A MY 198747A MY PI2019003643 A MYPI2019003643 A MY PI2019003643A MY PI2019003643 A MYPI2019003643 A MY PI2019003643A MY 198747 A MY198747 A MY 198747A
Authority
MY
Malaysia
Prior art keywords
composition
external use
alcohol
loxoprofen
comprises loxoprofen
Prior art date
Application number
MYPI2019003643A
Inventor
Hiroaki Okamoto
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of MY198747A publication Critical patent/MY198747A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

[Problem] Provided is a composition for external use that comprises loxoprofen as an active component, and that is prevented from browning with time. [Solution] The composition for external use comprises loxoprofen or a pharmaceutically acceptable salt thereof, capsaicinoid, and a C1-4 alcohol, wherein the alcohol is contained in an amount of 55 mass% or more based on the entire composition.
MYPI2019003643A 2016-12-27 2017-12-22 Composition for external use MY198747A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016254186A JP6847656B2 (en) 2016-12-27 2016-12-27 Topical composition
PCT/JP2017/046238 WO2018123906A1 (en) 2016-12-27 2017-12-22 Composition for external use

Publications (1)

Publication Number Publication Date
MY198747A true MY198747A (en) 2023-09-22

Family

ID=62707413

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019003643A MY198747A (en) 2016-12-27 2017-12-22 Composition for external use

Country Status (5)

Country Link
JP (1) JP6847656B2 (en)
CN (1) CN110099683B (en)
MY (1) MY198747A (en)
TW (1) TWI788316B (en)
WO (1) WO2018123906A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020045315A (en) * 2018-09-20 2020-03-26 興和株式会社 Pharmaceutical preparations containing loxoprofen
JP7226957B2 (en) * 2018-10-09 2023-02-21 小林製薬株式会社 External pharmaceutical composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014002599A1 (en) * 2012-06-25 2014-01-03 興和株式会社 Crude-drug-containing pharmaceutical composition
JP6060742B2 (en) * 2013-03-08 2017-01-18 ライオン株式会社 Liquid composition for external use
JP6344947B2 (en) * 2013-03-29 2018-06-20 興和株式会社 Loxoprofen-containing solid preparation for external use
JP6189668B2 (en) * 2013-07-31 2017-08-30 興和株式会社 Loxoprofen-containing external coating
WO2017111167A1 (en) * 2015-12-25 2017-06-29 興和株式会社 Pharmaceutical preparation containing loxoprofen

Also Published As

Publication number Publication date
TWI788316B (en) 2023-01-01
CN110099683A (en) 2019-08-06
JP6847656B2 (en) 2021-03-24
WO2018123906A1 (en) 2018-07-05
CN110099683B (en) 2023-01-13
JP2018104368A (en) 2018-07-05
TW201827046A (en) 2018-08-01

Similar Documents

Publication Publication Date Title
PH12020550622A1 (en) Kras g12c inhibitors
EP4512394A3 (en) Dosage forms and use thereof
MX382534B (en) Ophthalmological composition
PH12016502556A1 (en) Intermittent dosing of mdm2 inhibitor
EP4650370A3 (en) Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
WO2014153009A3 (en) Thiosaccharide mucolytic agents
TW201613592A (en) Glucose metabolism ameliorating agent
EP4696301A3 (en) A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof
PH12017502376A1 (en) Oral solid formulation containing irinotecan and method of preparing the same
PH12022551468A1 (en) Compounds active towards nuclear receptors
MX2017016774A (en) THERAPEUTIC AGENT FOR FIBROSIS.
MX389692B (en) COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH WITH MPC INHIBITORS.
MX2022007265A (en) Compounds active towards nuclear receptors.
MX2016015261A (en) Allisartan isoproxil solid dispersion and pharmaceutical composition thereof.
PH12020550232B1 (en) Pesticide composition containing thidiazuron and polyglutamic acid
MY200499A (en) Sulfonamide pharmaceutical composition
MX2016017142A (en) Allisartan isoproxil solid dispersion and pharmaceutical composition comprising same.
PH12018500817A1 (en) Pharmaceutical composition comprising metformin and lobeglitazone
MY198747A (en) Composition for external use
AU2017370226A1 (en) Pharmaceutical composition containing insulin-like growth factor-2 and use thereof
GEAP201914292A (en) Pharmaceutical formulations of vildagliptin
AU2017258649A1 (en) Covalent BTK inhibitors and uses thereof
MX2017006712A (en) Matrix metalloproteinase production inhibitor.
MY195763A (en) A Herbicidal Composition and Process Thereof
MX2020003513A (en) Active ingredient compositions comprising n-alkenoyl-n-alkylgluca mides and the use thereof.